Comparison of the nuclear matrix protein 22 with voided urine cytology in the diagnosis of transitional cell carcinoma of the bladder
No Thumbnail Available
Date
2004
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Several urinary markers for transitional cell carcinoma have been investigated, including urine cytology, bladder tumor antigen, autocrine motility factor receptor and fibrin degradation products. Unfortunately, they have poor overall sensitivity. The United States Food and Drug Administration have recently approved nuclear matrix protein (NMP 22) for the detection of occult or rapidly recurring disease after transurethral resection of bladder tumor. The objective of the current study was to assess the sensitivity of NMP 22 for the detection of bladder carcinoma, as well as to correlate the NMP 22 values with multiplicity of tumor, tumor size, configuration, stage and grade respectively. A total of 78 patients (38 with bladder cancer) provided a urine sample which was divided into appropriate aliquots for each of urine cytology and NMP 22. Comparative results demonstrate a clear superiority of NMP 22 in bladder cancer detection (52.6% vs 31.6% sensitivity), while specificity was in favor of urine cytology (100% vs 82.5%). For superficial tumors, sensitivity was 78.5% for NMP 22 and 41.6% for cytology and for invasive cancers, sensitivity was 90% for NMP 22 and 60% for cytology. Urinary NMP 22 levels were significantly correlated with tumor grade and were significantly higher in large tumors than small tumors. NMP 22 test results showed sufficient sensitivity in comparison with urine cytology for the detection of transitional cell carcinoma. However, we do not think that it is a useful tool as a substitute for endoscopic examination for the detection and surveillance in bladder cancer.
Description
Keywords
Carcinoma, Transitional Cell , Humans , Neoplasm Staging , Nuclear Proteins , Predictive Value of Tests , Prospective Studies , Reproducibility of Results , Sensitivity and Specificity , Tumor Burden , Tumor Markers, Biological , Turkey , Urinary Bladder Neoplasms , autocrine motility factor receptor , nuclear matrix protein , nuclear matrix protein 22 , tumor antigen , unclassified drug , article , bladder carcinoma , cancer diagnosis , cancer invasion , controlled study , diagnostic value , fibrinolysis , food and drug administration , human , major clinical study , priority journal , protein analysis , protein urine level , sensitivity analysis , transitional cell carcinoma , transurethral resection , tumor volume , urinalysis , urine cytology , urodynamics